Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Erik Schmok"'
Autor:
Catherine Bopp, Aline Salzmann, Silke Ohlmeier, Melanie Caspar, Erik Schmok, Sara Volz-Willems, Johannes Jäger, Fabian Dupont
Publikováno v:
International Medical Education, Vol 2, Iss 3, Pp 151-160 (2023)
(1) Background: This qualitative study aimed to identify and describe course components which affect a student’s motivation to learn within a blended-learning competency-based curriculum. (2) Methods: The data were gathered via two consecutive semi
Externí odkaz:
https://doaj.org/article/51d374f4c31a46fb85d10bdd3b67c764
Autor:
Erik Schmok, Mahin Abad Dar, Jochen Behrends, Hanna Erdmann, Dominik Rückerl, Tanja Endermann, Lisa Heitmann, Manuela Hessmann, Akihiko Yoshimura, Stefan Rose-John, Jürgen Scheller, Ulrich Emil Schaible, Stefan Ehlers, Roland Lang, Christoph Hölscher
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Suppressor of cytokine signaling 3 (SOCS3) is a feedback inhibitor of interleukin (IL)-6 signaling in macrophages. In the absence of this molecule, macrophages become extremely prone to an IL-6-dependent expression of arginase-1 (Arg1) and nitric oxi
Externí odkaz:
https://doaj.org/article/203401a6a1f745aaa490237d09c7d434
Autor:
Florian Recker, Peter Brossart, Erik Schmok, Valentin S. Schäfer, Elena Höhne, Tobias Raupach
Publikováno v:
Ultraschall in der Medizin - European Journal of Ultrasound. 44:194-202
Medical education has been transformed during the COVID-19 pandemic, creating challenges regarding adequate training in ultrasound (US). Due to the discontinuation of traditional classroom teaching, the need to expand digital learning opportunities i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4b921b27ac2f15629f3eab28849557
https://doi.org/10.1055/a-1528-1418
https://doi.org/10.1055/a-1528-1418
Autor:
Graham H. Bothamley, Helen R. Stagg, Onn Min Kon, Dean Creer, Heinke Kunst, Paramita Palchaudhuri, Erik Schmok, Maeve K. Lalor, Lucy Taylor, S Lozewicz, Tehreem Mohiyuddin, Timothy D. McHugh, Ibrahim Abubakar, Eliza Alexander, Jennifer Davidson, Patrick P. J. Phillips, Helen Booth, Miranda G. Loutet, H Milburn, Aula Abbara, Michael R. Loebinger, Marc Lipman, Ross J Harris
Publikováno v:
The European respiratory journal, vol 54, iss 4
Introduction2018 World Health Organization (WHO) guidelines for the treatment of isoniazid (H)-resistant (Hr) tuberculosis recommend a four-drug regimen: rifampicin (R), ethambutol (E), pyrazinamide (Z) and levofloxacin (Lfx), with or without H ([H]R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c8081ca471fe50a5ad0c174b510eb7
https://pubmed.ncbi.nlm.nih.gov/31601721
https://pubmed.ncbi.nlm.nih.gov/31601721
Autor:
Aula Abbara, Heinke Kunst, Ananna Rahman, Ppj Phillips, S Lozewicz, Mci Lipman, V. P. Kahr, Ibrahim Abubakar, Timothy D. McHugh, Maeve K. Lalor, U Gupta, Onn Min Kon, Erik Schmok, Paramita Palchaudhuri, Loebinger, C Cosgrove, H Burgess, E Holden, A Dunleavy, Graham H. Bothamley, Helen R. Stagg, F Perrin, L V Baker, Jennifer Davidson, H Milburn, Helen Booth, Eliza Alexander, Miranda G. Loutet
Publikováno v:
Optimising TB management.
2018 World Health Organization (WHO) guidelines for isoniazid resistant (INH-R) tuberculosis recommend a treatment regimen of four drugs continuously for six months- rifampicin, pyrazinamide, ethambutol, and levofloxacin; with or without isoniazid ([
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5c63893cec3b250e47aadc2688031a1
https://doi.org/10.1136/thorax-2018-212555.158
https://doi.org/10.1136/thorax-2018-212555.158
Autor:
Erik Schmok, Graham Bothamley
Publikováno v:
B57. IMPROVING OUTCOME IN TUBERCULOSIS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::933cfe44616de44e18adf1226da9f4fd
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3316
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3316